Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros

Banco de datos
País como asunto
Tipo del documento
Publication year range
1.
Harm Reduct J ; 21(1): 103, 2024 May 28.
Artículo en Inglés | MEDLINE | ID: mdl-38807226

RESUMEN

BACKGROUND: People in Connecticut are now more likely to die of a drug-related overdose than a traffic accident. While Connecticut has had some success in slowing the rise in overdose death rates, substantial additional progress is necessary. METHODS: We developed, verified, and calibrated a mechanistic simulation of alternative overdose prevention policy options, including scaling up naloxone (NLX) distribution in the community and medications for opioid use disorder (OUD) among people who are incarcerated (MOUD-INC) and in the community (MOUD-COM) in a simulated cohort of people with OUD in Connecticut. We estimated how maximally scaling up each option individually and in combinations would impact 5-year overdose deaths, life-years, and quality-adjusted life-years. All costs were assessed in 2021 USD, employing a health sector perspective in base-case analyses and a societal perspective in sensitivity analyses, using a 3% discount rate and 5-year and lifetime time horizons. RESULTS: Maximally scaling NLX alone reduces overdose deaths 20% in the next 5 years at a favorable incremental cost-effectiveness ratio (ICER); if injectable rather than intranasal NLX was distributed, 240 additional overdose deaths could be prevented. Maximally scaling MOUD-COM and MOUD-INC alone reduce overdose deaths by 14% and 6% respectively at favorable ICERS. Considering all permutations of scaling up policies, scaling NLX and MOUD-COM together is the cost-effective choice, reducing overdose deaths 32% at ICER $19,000/QALY. In sensitivity analyses using a societal perspective, all policy options were cost saving and overdose deaths reduced 33% over 5 years while saving society $338,000 per capita over the simulated cohort lifetime. CONCLUSIONS: Maximally scaling access to naloxone and MOUD in the community can reduce 5-year overdose deaths by 32% among people with OUD in Connecticut under realistic budget scenarios. If societal cost savings due to increased productivity and reduced crime costs are considered, one-third of overdose deaths can be reduced by maximally scaling all three policy options, while saving money.


Asunto(s)
Análisis Costo-Beneficio , Sobredosis de Droga , Naloxona , Antagonistas de Narcóticos , Trastornos Relacionados con Opioides , Humanos , Connecticut/epidemiología , Naloxona/uso terapéutico , Trastornos Relacionados con Opioides/mortalidad , Antagonistas de Narcóticos/uso terapéutico , Sobredosis de Droga/mortalidad , Sobredosis de Droga/prevención & control , Sobredosis de Opiáceos/mortalidad , Sobredosis de Opiáceos/prevención & control , Reducción del Daño , Adulto , Masculino , Años de Vida Ajustados por Calidad de Vida , Femenino , Prisioneros/estadística & datos numéricos
SELECCIÓN DE REFERENCIAS
Detalles de la búsqueda